Throughout the pandemic, B.C.’s post-secondary institutions have maintained a coordinated approach that is rooted in evidence-based Public Health guidance.
As students, faculty and staff begin a new term, Public Health recommends the continued following of good health practices.
Additional information for Post Secondary studies, such as PSI specific Communicable Disease Prevention plans can be found here.
Thank you for the important role you play in supporting the provincial COVID-19 response.
At CCTB, the well-being, safety and success of our students are top priority. With the CCTB COVID-19 refund guarantee, students can start studying online with peace of mind while waiting for the outcome of their study permit.
Students who commence a program online for any of the 2021-2023 start dates, after applying for their study permit with IRCC, and receive a visa refusal will now be eligible for a full refund.
To qualify for the refund, students must submit their visa refusal letter within five (5) business days of receiving the refusal letter. The refund will exclude the non-refundable $250 administration fee.
Terms and Conditions for CCTB COVID- 19 Refund Guarantee
Since the beginning of the pandemic, the Government of Canada has taken a layered approach to border management to protect the health and safety of Canadians. As the pandemic situation has continued to evolve, adjustments to border measures have been informed by the latest evidence, available data, operational considerations, and the epidemiological situation, both in Canada and internationally.
The Government of Canada announced the removal of all COVID-19 entry restrictions, as well as testing, quarantine, and isolation requirements for anyone entering Canada, effective October 1, 2022.
The removal of border measures has been facilitated by a number of factors, including modelling that indicates that Canada has largely passed the peak of the Omicron BA.4 and BA.5 fuelled wave, Canada’s high vaccination rates, lower hospitalization and death rates, as well as the availability and use of vaccine boosters (including new bivalent formulation), rapid tests, and treatments for COVID-19.
For more information, please see this link